Company of the Month: Interpace Diagnostics
...
Already a member? Log in here
Reimbursement Trends: 8 Molecular Assays Score Big Coverage Wins from Medicare, Private Insurers
...
Already a member? Log in here
Medicare Reimbursement: 4 Molecular Assays Score Big Coverage Wins
...
Already a member? Log in here
Cutting Edge Dx Approvals Threaten FDA’s Fuddy-Duddy Reputation
From - National Intelligence Report
A trio of recent FDA product approvals in the diagnostics space have belied the agency's traditional reputation for resisting medical innovation. Here's the timeline for…
Already a member? Log in here
Companion Diagnostics Driving New Model for Pharma-Dx Partnerships
US oncology patients are missing out on targeted therapies due to a combination of testing "quality gaps" and slow test diffusion
Already a member? Log in here